INHIBITION OF GLYCOSPHINGOLIPID SYNTHESIS STRONGLY REDUCES ATHEROSCLEROSIS DEVELOPMENT IN APOE*3 LEIDEN MICE

被引：0
|
作者：
Bietrix, F. [1 ]
Lombardo, E. [1 ]
van Roomen, C. [1 ]
Ottenhoff, R. [1 ]
Groen, A. [1 ]
Aerts, J. [1 ]
机构：
[1] AMC, Amsterdam, Netherlands
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Inhibition of Glycosphingolipid Synthesis Induces a Profound Reduction of Plasma Cholesterol and Inhibits Atherosclerosis Development in APOE*3 Leiden and Low-Density Lipoprotein Receptor-/- Mice
    Bietrix, Florence
    Lombardo, Elisa
    van Roomen, Cindy P. A. A.
    Ottenhoff, Roelof
    Vos, Mariska
    Rensen, Patrick C. N.
    Verhoeven, Arthur J.
    Aerts, Johannes M.
    Groen, Albert K.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (05) : 931 - U108
  • [2] PPAR Δ AGONIST GW501516 STRONGLY PREVENTS DEVELOPMENT OF ATHEROSCLEROSIS IN APOE*3LEIDEN MICE
    van der Hoorn, J.
    van den Hoogen, C.
    Pieterman, E.
    Princen, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [3] Ritonavir protects against the development of atherosclerosis in APOE*3-Leiden mice
    den Boer, Marion A. M.
    Westerterp, Marit
    de Vries-van der Weij, Jitske
    Wang, Yanan
    Hu, Lihui
    Santo, Sonia M. S. Espirito
    Kooistra, Teake
    Reiss, Peter
    Romijn, Johannes A.
    Havekes, Louis M.
    Rensen, Patrick C. N.
    ATHEROSCLEROSIS, 2010, 210 (02) : 381 - 387
  • [4] Tesaglitazar, a dual PPARα/γ agonist, reduces atherosclerosis in APOE*3Leiden transgenic mice
    Havekes, LM
    Zadelaar, SM
    Boesten, LSM
    Jukema, WJ
    Van Vlijmen, BJM
    Lundholm, E
    Camejo, G
    DIABETES, 2005, 54 : A233 - A234
  • [5] Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol
    Kuhnast, Susan
    Louwe, Mieke C.
    Heemskerk, Mattijs M.
    Pieterman, Elsbet J.
    van Klinken, Jan B.
    van den Berg, Sjoerd A. A.
    Smit, Johannes W. A.
    Havekes, Louis M.
    Rensen, Patrick C. N.
    van der Hoorn, Jose W. A.
    Princen, Hans M. G.
    Jukema, J. Wouter
    PLOS ONE, 2013, 8 (06):
  • [6] Resveratrol Protects Against Atherosclerosis Development in APOE☆3-Leiden.CETP Mice
    Berbee, Jimmy F.
    Wong, Man-Chi
    Wang, Yanang
    Van der Hoorn, Jose W.
    Romijn, Johannes A.
    Havekes, Louis M.
    Princen, Hans M.
    Rensen, Patrick C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E42 - E43
  • [7] RESVERATROL PROTECTS AGAINST ATHEROSCLEROSIS DEVELOPMENT IN APOE*3-LEIDEN.CETP MICE
    Berbee, J.
    Wong, M-C
    Wang, Y.
    van der Hoorn, J.
    Romijn, J.
    Havekes, L.
    Princen, H.
    Rensen, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [8] RESVERATROL PROTECTS AGAINST ATHEROSCLEROSIS DEVELOPMENT IN APOE*3-LEIDEN-CETP MICE
    Berbee, J.
    Wong, M. -C.
    Wang, Y.
    van der Hoorn, J.
    Romijn, H.
    Havekes, L.
    Princen, H.
    Rensen, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 22 - 22
  • [9] Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans
    van Keulen, Danielle
    Pouwer, Marianne G.
    Emilsson, Valur
    Matic, Ljubica Perisic
    Pieterman, Elsbet J.
    Hedin, Ulf
    Gudnason, Vilmundur
    Jennings, Lori L.
    Holmstrom, Kim
    Nielsen, Boye Schnack
    Pasterkamp, Gerard
    Lindeman, Jan H. N.
    van Gool, Alain J.
    Gelpke, Maarten D. Sollewijn
    Princen, Hans M. G.
    Tempel, Dennie
    PLOS ONE, 2019, 14 (08):
  • [10] Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in ApoE*3 Leiden transgenic mice
    Lardenoye, JWH
    De Vries, M
    Van Bockel, H
    Van Hinsbergh, V
    Quax, P
    CIRCULATION, 2001, 104 (17) : 713 - 713
12345